Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study
- PMID: 35218727
- PMCID: PMC11348720
- DOI: 10.1016/j.ahj.2022.02.010
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study
Abstract
Background: Shared decision making (SDM) improves the likelihood that patients will receive care in a manner consistent with their priorities. To facilitate SDM, decision aids (DA) are commonly used, both to prepare a patient before their clinician visit, as well as to facilitate discussion during the visit. However, the relative efficacy of patient-focused or encounter-based DAs on SDM and patient outcomes remains largely unknown. We aim to directly estimate the comparative effectiveness of two DA's on SDM observed in encounters to discuss stroke prevention strategies in patients with atrial fibrillation (AF).
Methods: The study aims to recruit 1200 adult patients with non-valvular AF who qualify for anticoagulation therapy, and their clinicians who manage stroke prevention strategies, in a 2x2 cluster randomized multi-center trial at six sites. Two DA's were developed as interactive, online, non-linear tools: a patient decision aid (PDA) to be used by patients before the encounter, and an encounter decision aid (EDA) to be used by clinicians with their patients during the encounter. Patients will be randomized to PDA or usual care; clinicians will be randomized to EDA or usual care.
Results: Primary outcomes are quality of SDM, patient decision making, and patient knowledge. Secondary outcomes include anticoagulation choice, adherence, and clinical events.
Conclusion: This trial is the first randomized, head-to-head comparison of the effects of an EDA versus a PDA on SDM. Our results will help to inform future SDM interventions to improve patients' AF outcomes and experiences with stroke prevention strategies.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest Dr Steinberg reports research support from Abbott, Cardiva, AltaThera, Boston Scientific, and Janssen; and consulting to Janssen, AltaThera, Merit Medical, and Crowley Fleck, LLP; and speaking for NACCME (funded by Sanofi). Dr Witt reports research support from and consulting to Roche Diagnostics. Dr Barnes reports consulting for Pfizer/Bristol-Myers Squibb, Janssen, and Acelis Connected Health. Dr Noseworthy is a study investigator in an ablation trial sponsored by Medtronic, is involved in potential equity/royalty relationship with AliveCor, has served on an expert advisory panel for Optum, and has filed patents related to the application of AI to the ECG for diagnosis and risk stratification.
Figures
Similar articles
-
Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial.JAMA Intern Med. 2020 Sep 1;180(9):1215-1224. doi: 10.1001/jamainternmed.2020.2908. JAMA Intern Med. 2020. PMID: 32897386 Free PMC article. Clinical Trial.
-
Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.Trials. 2017 Sep 29;18(1):443. doi: 10.1186/s13063-017-2178-y. Trials. 2017. PMID: 28962662 Free PMC article. Clinical Trial.
-
Effect of Shared Decision-Making for Stroke Prevention on Treatment Adherence and Safety Outcomes in Patients With Atrial Fibrillation: A Randomized Clinical Trial.J Am Heart Assoc. 2022 Jan 18;11(2):e023048. doi: 10.1161/JAHA.121.023048. Epub 2022 Jan 13. J Am Heart Assoc. 2022. PMID: 35023356 Free PMC article. Clinical Trial.
-
Decision aids for shared decision-making and appropriate anticoagulation therapy in patients with atrial fibrillation: a systematic review and meta-analysis.Eur J Cardiovasc Nurs. 2022 Mar 3;21(2):97-106. doi: 10.1093/eurjcn/zvab085. Eur J Cardiovasc Nurs. 2022. PMID: 34550376
-
Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan.Med Decis Making. 2021 Jul;41(5):540-549. doi: 10.1177/0272989X211005655. Epub 2021 Apr 24. Med Decis Making. 2021. PMID: 33896270 Free PMC article.
Cited by
-
Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trial.BMJ. 2025 Jan 9;388:e079976. doi: 10.1136/bmj-2024-079976. BMJ. 2025. PMID: 39788611 Free PMC article. Clinical Trial.
-
Identifying and addressing underuse in hematologic care through systems-based hematology.Res Pract Thromb Haemost. 2025 May 8;9(4):102881. doi: 10.1016/j.rpth.2025.102881. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40519877 Free PMC article. Review.
-
Assessment of a venous thromboembolism prophylaxis shared decision-making intervention (DASH-TOP) using the decisional conflict scale: a mixed-method study.BMC Med Inform Decis Mak. 2023 Nov 6;23(1):250. doi: 10.1186/s12911-023-02349-3. BMC Med Inform Decis Mak. 2023. PMID: 37932759 Free PMC article. Clinical Trial.
-
Development of Complementary Encounter and Patient Decision Aids for Shared Decision Making about Stroke Prevention in Atrial Fibrillation.MDM Policy Pract. 2023 Jun 21;8(1):23814683231178033. doi: 10.1177/23814683231178033. eCollection 2023 Jan-Jun. MDM Policy Pract. 2023. PMID: 38178866 Free PMC article.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30. Circulation. 2024. PMID: 38033089 Free PMC article.
References
-
- Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370–5. - PubMed
-
- Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042–6. - PubMed
-
- Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009;104:1534–9. - PubMed
-
- Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003;290:2685–92. - PubMed
-
- Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492–501. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical